Kelly Rose
- Pharmacology top 1%
- Molecular Biology
- Oncology
- Endocrinology, Diabetes and Metabolism top 10%
- Hepatology top 5%
- Co-authors
- Jasminder SahiEdward L. LeCluyseXianxian ZhengNalini SadagopanMelvin E. AndersenSonia M. F. de MoraisJames R. SowersPaul R. Standley
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Drug Transport and Resistance Mechanisms (10 papers)Drug-Induced Hepatotoxicity and Protection (8 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyAnalytical Biochemistry
- Partner nations
- United StatesUnited KingdomNorway
In The Last Decade
Kelly Rose
32 papers receiving 896 citations
Peers
Comparison fields: 5 of 107
- Pharmacology 301
- Molecular Biology 223
- Oncology 204
- Endocrinology, Diabetes and Metabolism 135
- Hepatology 129
Countries citing papers authored by Kelly Rose
This map shows the geographic impact of Kelly Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Rose more than expected).
Fields of papers citing papers by Kelly Rose
This network shows the impact of papers produced by Kelly Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Rose. The network helps show where Kelly Rose may publish in the future.
Co-authorship network of co-authors of Kelly Rose
This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Rose. A scholar is included among the top collaborators of Kelly Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Rose. Kelly Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 34 | |
| 6 | 1 | |
| 7 | 71 | |
| 8 | 14 | |
| 9 | 26 | |
| 10 | 4 | |
| 11 | 54 | |
| 12 | 22 | |
| 13 | 99 | |
| 14 | 19 | |
| 15 | 55 | |
| 16 | 83 | |
| 17 | 38 | |
| 18 | 16 | |
| 19 | 103 | |
| 20 | 21 |
About Kelly Rose
Kelly Rose is a scholar working on Pharmacology, Hepatology and Pharmacy, having authored 33 papers that have together received 918 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Drug Transport and Resistance Mechanisms (10 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). The work is most often cited by research in Pharmacology (301 citations), Hepatology (129 citations) and Molecular Medicine (42 citations). Kelly Rose has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Jasminder Sahi, Edward L. LeCluyse, Xianxian Zheng, Nalini Sadagopan, Melvin E. Andersen, Sonia M. F. de Morais, James R. Sowers, Paul R. Standley, Melissa Runge‐Morris and Jeffrey L. Ram. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.